Focus Areas
OPHTHALMOLOGICAL
DRY EYE DIAGNOSTICS
AXIM is currently preparing a 510(k) submission to seek FDA clearance to commercialize its updated Lactoferrin diagnostic device and intends to submit a subsequent 510(k) application for its updated IgE diagnostic test.
These products are under development and have not yet received clearance from the U.S. Food and Drug Administration.
CANCER
Using proprietary polyclonal antibodies in collaboration with world-renowned research and academic centers, AXIM has developed a prototype diagnostic test that measures levels of QSOX1-L in blood and filed for patent protection.
TEST DEVELOPMENT
INNOVATIVE DIAGNOSTIC SOLUTIONS
AXIM works with clients around the world on development of diagnostic solutions of all kinds for a variety of conditions and indications. For more information, please contact AXIM.